Mosunetuzumab ELISA Kit

SKU:BHE21400323
Overview
Click light‑blue chips for details
Mosunetuzumab ELISA Kit is a quantitative colorimetric ELISA for measuring Mosunetuzumab levels in plasma, serum. The assay covers a 0.31-5 μg/mL standard-curve range, detects down to 0.156 μg/mL, with typical spike recovery of 80-120%, supporting reproducible standard-curve quantification across experimental conditions.
Assay Type Quantitative Colorimetric ELISA
Sample Type Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Plate Format 96-well (96T)
Options selector
Catalog no. Size
DY257068-96T 96 T
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 96 T
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
  • Shipping: 2-8 °C
  • Upon receipt: refrigerate upon receipt.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Target Mosunetuzumab
Alternative names BTCT4465A, RG-7828, RO7030816
UniProt # P11836 & P07766
CAS no. 1905409-39-3
Reactivity
  • Human
Applications
  • ELISA
Assay type
  • Quantitative
Sample type(s) Plasma, Serum
Sensitivity 0.156 μg/mL
Detection range 0.31-5 μg/mL
Detection method
  • Colorimetric
Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 ℃
Catalog no. (Mfr.) DY257068
Main SKU BHE21400323
Therapeutic Drug Monitoring

Assay Principle

Mosunetuzumab ELISA Kit provides plate-based quantitative measurement of Mosunetuzumab. Each run carries its own standard series, so results remain comparable across plates, days, and operators in a research workflow.

Background

Polatuzumab vedotin is an active ingredient of Polivy, a drug product for the treatment of previously treated adult patients with diffuse large B-cell lymphoma (DLBCL) in combination with bendamustine and rituximab. Polatuzumab vedotin is an antibody-drug conjugate composed of a humanized monoclonal antibody (mAb) targeting B-cell antigen receptor complex-associated protein beta chain (CD79b) and a microtubule-disrupting toxin, monomethyl auristatin E (MMAE). This drug was developed by Genentech/Roche using a proprietary technology developed by Seattle Genetics. In 2018, orphan designation was granted for polatuzumab vedotin for the treatment of diffuse large B-cell lymphoma by the European Commission to Roche Registration Limited. Based on the effective therapeutic effect of polatuzumab vedotin on DLBCL, the U.S. Food and Drug Administration (FDA) granted accelerated approval to polatuzumab vedotin, in combination with bendamustine plus rituximab on 10 June 2019. Subsequently, the European Medicines Health and Therapeutic Goods Administration of Australian Drug Regulatory Administration also approved Polivy's sales authorization from Genentech. Besides DLBCL, polatuzumab vedotin also has been investigated in the treatment of non-hodgkins lymphoma, chronic lymphocytic leukemia, follicular lymphoma. Some of the trials were complicated, and there are six clinical trials still undergoing now. For example, there is a phase Ib/II study investigating the safety, tolerability, pharmacokinetics, and efficacy of mosunetuzumab (BTCT4465A) in combination with chop or chp-polatuzumab vedotin in participants with b-cell non-hodgkin lymphoma. Furthermore, a study to evaluate the safety and efficacy of polatuzumab vedotin in combination with rituximab, gemcitabine and oxaliplatin compared to rituximab, gemcitabine and oxaliplatin alone in participants with relapsed or refractory diffuse large B-cell lymphoma is recruiting. The recent events of polatuzumab vedotin is that Chugai Pharmaceutical, another developer, adverse events data from a phase ii (jo40762/p-drive) trial diffuse large B-cell lymphoma and announces intention to submit NDA to Ministry of Health, Labour and Welfare for diffuse large B-cell lymphoma in Japan on February 2020. At the same period, a phase-II clinical trials in diffuse large B cell lymphoma is undergoing in United Kingdom (IV).

Specifications

Assay Type Quantitative Colorimetric ELISA
Detection Method Colorimetric
Plate Format 96-well (96T)
Sample Types Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Recovery 80-120%
Stability & Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 °C
CAS Number 1905409-39-3
UniProt P11836 & P07766
Alternative Names BTCT4465A, RG-7828, RO7030816

Performance Data

The kit provides a quantitative range of 0.31-5 μg/mL, an analytical sensitivity of 0.156 μg/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.

Target Notes

The target is also referenced in the literature as BTCT4465A, RG-7828, RO7030816. Curated target information is available under UniProt accession P11836 & P07766. The corresponding compound is registered under CAS 1905409-39-3.

Common Research Applications

  • Pharmacokinetic profiling of the drug in preclinical and translational research models
  • Bioanalytical method development, bridging, and comparability studies
  • Stability and formulation studies requiring reproducible concentration readouts

Safety & Handling

For Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.

Q.Which sample types are compatible with this kit?
A.The kit is validated for Plasma, Serum. For other matrices, evaluate dilution linearity and spike recovery before routine use.
Q.What is the detection limit?
A.The analytical sensitivity is 0.156 μg/mL. Samples near the detection limit should be run with replicates for reliable interpretation.
Q.What is the quantitative range?
A.The standard curve covers 0.31-5 μg/mL. Dilute concentrated samples so readings fall within this range.
Q.How should the kit be stored?
A.The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Q.How is the kit shipped?
A.The kit ships at 2-8 °C. Refrigerate upon receipt and follow the datasheet for component-level storage.
Q.Is this kit for diagnostic use?
A.No. This product is For Research Use Only (RUO) and is not intended for diagnostic or therapeutic procedures.

Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Matches this product
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today